当前位置:首页 - 行情中心 - 安图生物(603658) - 财务分析 - 现金流量表

安图生物

(603658)

  

流通市值:219.77亿  总市值:219.77亿
流通股本:5.71亿   总股本:5.71亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,420,516,955.892,198,247,562.321,121,264,719.64,876,632,472.1
  收到的税费返还15,518,648.518,453,225.55-35,526,258.94
  收到其他与经营活动有关的现金145,726,926.86113,353,151.9689,678,591.42181,636,034.28
  经营活动现金流入小计3,581,762,531.262,320,053,939.831,210,943,311.025,093,794,765.32
  购买商品、接受劳务支付的现金1,076,737,751.87727,322,634.79373,420,356.811,642,915,029.71
  支付给职工以及为职工支付的现金916,538,119.4673,170,786.68476,776,379.071,168,421,510.44
  支付的各项税费375,636,923.81262,991,988.1772,647,267.29429,424,829.3
  支付其他与经营活动有关的现金367,427,922.79246,384,604.84121,760,849.59543,750,654.75
  经营活动现金流出小计2,736,340,717.871,909,870,014.481,044,604,852.763,784,512,024.2
  经营活动产生的现金流量净额845,421,813.39410,183,925.35166,338,458.261,309,282,741.12
二、投资活动产生的现金流量:
  取得投资收益收到的现金894,348894,348--
  处置固定资产、无形资产和其他长期资产收回的现金净额109,282.310,082.36,000206,937.34
  收到的其他与投资活动有关的现金4,039,062,461.622,767,068,985.8410,018,513.892,622,846,961.49
  投资活动现金流入小计4,040,066,091.922,767,973,416.1410,024,513.892,623,053,898.83
  购建固定资产、无形资产和其他长期资产支付的现金464,971,414.97326,499,808.64146,794,114.2664,401,544.3
  投资支付的现金7,500,0007,500,0007,500,00055,500,000
  取得子公司及其他营业单位支付的现金---1,761,567.47
  支付其他与投资活动有关的现金3,329,162,589.432,131,839,077.53236,722,718.033,086,618,209.92
  投资活动现金流出小计3,801,634,004.42,465,838,886.17391,016,832.233,808,281,321.69
  投资活动产生的现金流量净额238,432,087.52302,134,529.97-380,992,318.34-1,185,227,422.86
三、筹资活动产生的现金流量:
  吸收投资收到的现金14,455,00014,455,00014,455,000-
  其中:子公司吸收少数股东投资收到的现金14,455,00014,455,00014,455,000-
  取得借款收到的现金361,670,786.89361,670,786.89291,970,786.89503,000,000
  收到其他与筹资活动有关的现金1,206,334,001.7919,397,210.85439,770,402.48783,955,484.92
  筹资活动现金流入小计1,582,459,788.591,295,522,997.74746,196,189.371,286,955,484.92
  偿还债务支付的现金852,670,786.89779,970,786.89488,000,000654,000,000
  分配股利、利润或偿付利息支付的现金728,357,690.12727,179,676.693,463,420.84627,310,854.28
  其中:子公司支付给少数股东的股利、利润2,102,1002,102,100-3,930,600
  支付其他与筹资活动有关的现金947,974,071.45501,655,814.9275,840,504.051,164,474,576.14
  筹资活动现金流出小计2,529,002,548.462,008,806,278.48767,303,924.892,445,785,430.42
  筹资活动产生的现金流量净额-946,542,759.87-713,283,280.74-21,107,735.52-1,158,829,945.5
四、汇率变动对现金及现金等价物的影响2,418,501.373,246,257.443,228,949.871,463,670.6
五、现金及现金等价物净增加额139,729,642.412,281,432.02-232,532,645.73-1,033,310,956.64
  加:期初现金及现金等价物余额452,058,348.81452,058,348.81452,058,348.811,485,369,305.45
  期末现金及现金等价物余额591,787,991.22454,339,780.83219,525,703.08452,058,348.81
补充资料:
  净利润-578,036,989.75-1,199,233,279.89
  资产减值准备-14,215,837.01-62,954,217.56
  固定资产和投资性房地产折旧-215,464,941.83-433,709,122.57
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-215,464,941.83-433,709,122.57
  无形资产摊销-13,748,734.82-30,492,330.54
  长期待摊费用摊销-12,897,921.42-31,454,036.31
  处置固定资产、无形资产和其他长期资产的损失--38,609.84-1,169,696.21
  固定资产报废损失-1,562,991.87-11,355,581.92
  公允价值变动损失-54,112.42--3,609,780.75
  财务费用-9,517,542.81-21,653,584.35
  投资损失--67,250,439.05--92,272,195.9
  递延所得税--529,134.49--34,884,593.88
  其中:递延所得税资产减少--20,410,900.74--61,041,511.47
    递延所得税负债增加-19,881,766.25-26,156,917.59
  存货的减少-57,006,242.84--365,941,785.02
  经营性应收项目的减少--215,522,717.17--62,360,213
  经营性应付项目的增加--204,841,745.56--36,953,893.1
  其他--7,539,635.35-44,094,456.33
  现金的期末余额-454,339,780.83-452,058,348.81
  减:现金的期初余额-452,058,348.81-1,485,369,305.45
  现金及现金等价物的净增加额-2,281,432.02--1,033,310,956.64
公告日期2025-10-302025-08-222025-04-182025-04-18
审计意见(境内)标准无保留意见
TOP↑